Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs
Identifieur interne : 000E56 ( Istex/Corpus ); précédent : 000E55; suivant : 000E57Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs
Auteurs : Susanne A. Schneider ; Vrajesh Udani ; Charulata Sawant Sankhla ; Kailash P. BhatiaSource :
- Movement Disorders [ 0885-3185 ] ; 2009-06-15.
English descriptors
- KwdEn :
Abstract
Adverse events of dopamine‐blocking agents include acute dystonic reactions and oculogyric crises (OGCs). OGCs may be recurrent on maintenance of or re‐exposure to the drug. Thus, complete withdrawal is recommended. Recurrent episodes of acute dystonia despite withdrawal and the lack of further exposure to antidopaminergic agents are usually not seen. Here, we report three cases with recurrent OGCs despite complete withdrawal of neuroleptics. Triggering or priming factors were a single dose of haloperidol in two cases and a single dose of metoclopramide in one case. Episodes reoccurred spontaneously, but responded to anticholinergics. The pathomechanisms of acute dystonic reactions and OGCs remain unclear. Parallels to levodopa‐induced dyskinesias in Parkinson's disease, as well as to dopa‐responsive dystonia, paroxysmal dyskinesias, and channelopathies are discussed here. Whether there is a genetic susceptibility or some other reason for only some patients developing this phenomenon remains unclear. © 2009 Movement Disorder Society
Url:
DOI: 10.1002/mds.22532
Links to Exploration step
ISTEX:F8EDE61931B7C100D8C289490EDA4EEB8B244F4BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs</title><author><name sortKey="Schneider, Susanne A" sort="Schneider, Susanne A" uniqKey="Schneider S" first="Susanne A." last="Schneider">Susanne A. Schneider</name><affiliation><mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Udani, Vrajesh" sort="Udani, Vrajesh" uniqKey="Udani V" first="Vrajesh" last="Udani">Vrajesh Udani</name><affiliation><mods:affiliation>Department of Pediatrics and Neurology, PD Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai, India</mods:affiliation></affiliation></author><author><name sortKey="Sankhla, Charulata Sawant" sort="Sankhla, Charulata Sawant" uniqKey="Sankhla C" first="Charulata Sawant" last="Sankhla">Charulata Sawant Sankhla</name><affiliation><mods:affiliation>Department of Pediatrics and Neurology, PD Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai, India</mods:affiliation></affiliation></author><author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name><affiliation><mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F8EDE61931B7C100D8C289490EDA4EEB8B244F4B</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1002/mds.22532</idno><idno type="url">https://api.istex.fr/document/F8EDE61931B7C100D8C289490EDA4EEB8B244F4B/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000E56</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs</title><author><name sortKey="Schneider, Susanne A" sort="Schneider, Susanne A" uniqKey="Schneider S" first="Susanne A." last="Schneider">Susanne A. Schneider</name><affiliation><mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Udani, Vrajesh" sort="Udani, Vrajesh" uniqKey="Udani V" first="Vrajesh" last="Udani">Vrajesh Udani</name><affiliation><mods:affiliation>Department of Pediatrics and Neurology, PD Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai, India</mods:affiliation></affiliation></author><author><name sortKey="Sankhla, Charulata Sawant" sort="Sankhla, Charulata Sawant" uniqKey="Sankhla C" first="Charulata Sawant" last="Sankhla">Charulata Sawant Sankhla</name><affiliation><mods:affiliation>Department of Pediatrics and Neurology, PD Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai, India</mods:affiliation></affiliation></author><author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name><affiliation><mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-06-15">2009-06-15</date><biblScope unit="vol">24</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="1226">1226</biblScope><biblScope unit="page" to="1229">1229</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">F8EDE61931B7C100D8C289490EDA4EEB8B244F4B</idno><idno type="DOI">10.1002/mds.22532</idno><idno type="ArticleID">MDS22532</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>acute dystonic reaction</term><term>antidopaminergic treatment</term><term>dystonia</term><term>neuroleptics</term><term>oculogyric crisis</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Adverse events of dopamine‐blocking agents include acute dystonic reactions and oculogyric crises (OGCs). OGCs may be recurrent on maintenance of or re‐exposure to the drug. Thus, complete withdrawal is recommended. Recurrent episodes of acute dystonia despite withdrawal and the lack of further exposure to antidopaminergic agents are usually not seen. Here, we report three cases with recurrent OGCs despite complete withdrawal of neuroleptics. Triggering or priming factors were a single dose of haloperidol in two cases and a single dose of metoclopramide in one case. Episodes reoccurred spontaneously, but responded to anticholinergics. The pathomechanisms of acute dystonic reactions and OGCs remain unclear. Parallels to levodopa‐induced dyskinesias in Parkinson's disease, as well as to dopa‐responsive dystonia, paroxysmal dyskinesias, and channelopathies are discussed here. Whether there is a genetic susceptibility or some other reason for only some patients developing this phenomenon remains unclear. © 2009 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Susanne A. Schneider MD, PhD</name><affiliations><json:string>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom</json:string></affiliations></json:item><json:item><name>Vrajesh Udani MD</name><affiliations><json:string>Department of Pediatrics and Neurology, PD Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai, India</json:string></affiliations></json:item><json:item><name>Charulata Sawant Sankhla MD</name><affiliations><json:string>Department of Pediatrics and Neurology, PD Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai, India</json:string></affiliations></json:item><json:item><name>Kailash P. Bhatia MD, FRCP</name><affiliations><json:string>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>oculogyric crisis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>acute dystonic reaction</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>dystonia</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>neuroleptics</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>antidopaminergic treatment</value></json:item></subject><language><json:string>eng</json:string></language><abstract>Adverse events of dopamine‐blocking agents include acute dystonic reactions and oculogyric crises (OGCs). OGCs may be recurrent on maintenance of or re‐exposure to the drug. Thus, complete withdrawal is recommended. Recurrent episodes of acute dystonia despite withdrawal and the lack of further exposure to antidopaminergic agents are usually not seen. Here, we report three cases with recurrent OGCs despite complete withdrawal of neuroleptics. Triggering or priming factors were a single dose of haloperidol in two cases and a single dose of metoclopramide in one case. Episodes reoccurred spontaneously, but responded to anticholinergics. The pathomechanisms of acute dystonic reactions and OGCs remain unclear. Parallels to levodopa‐induced dyskinesias in Parkinson's disease, as well as to dopa‐responsive dystonia, paroxysmal dyskinesias, and channelopathies are discussed here. Whether there is a genetic susceptibility or some other reason for only some patients developing this phenomenon remains unclear. © 2009 Movement Disorder Society</abstract><qualityIndicators><score>6.752</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1048</abstractCharCount><pdfWordCount>14082</pdfWordCount><pdfCharCount>92907</pdfCharCount><pdfPageCount>24</pdfPageCount><abstractWordCount>146</abstractWordCount></qualityIndicators><title>Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs</title><genre><json:string>Serial article</json:string></genre><host><volume>24</volume><pages><total>5</total><last>1229</last><first>1226</first></pages><issn><json:string>0885-3185</json:string></issn><issue>8</issue><subject><json:item><value>Brief Report</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2009</publicationDate><copyrightDate>2009</copyrightDate><doi><json:string>10.1002/mds.22532</json:string></doi><id>F8EDE61931B7C100D8C289490EDA4EEB8B244F4B</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/F8EDE61931B7C100D8C289490EDA4EEB8B244F4B/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/F8EDE61931B7C100D8C289490EDA4EEB8B244F4B/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/F8EDE61931B7C100D8C289490EDA4EEB8B244F4B/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>2009</date></publicationStmt><notesStmt><note type="content">*Potential conflict of interest: None reported.</note><note>Brain Research Trust, UK</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs</title><author><persName><forename type="first">Susanne A.</forename><surname>Schneider</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom</affiliation></author><author><persName><forename type="first">Vrajesh</forename><surname>Udani</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Pediatrics and Neurology, PD Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai, India</affiliation></author><author><persName><forename type="first">Charulata Sawant</forename><surname>Sankhla</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Pediatrics and Neurology, PD Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai, India</affiliation></author><author><persName><forename type="first">Kailash P.</forename><surname>Bhatia</surname><roleName type="degree">MD, FRCP</roleName></persName><note type="correspondence"><p>Correspondence: Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom</p></note><affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-06-15"></date><biblScope unit="vol">24</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="1226">1226</biblScope><biblScope unit="page" to="1229">1229</biblScope></imprint></monogr><idno type="istex">F8EDE61931B7C100D8C289490EDA4EEB8B244F4B</idno><idno type="DOI">10.1002/mds.22532</idno><idno type="ArticleID">MDS22532</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2009</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Adverse events of dopamine‐blocking agents include acute dystonic reactions and oculogyric crises (OGCs). OGCs may be recurrent on maintenance of or re‐exposure to the drug. Thus, complete withdrawal is recommended. Recurrent episodes of acute dystonia despite withdrawal and the lack of further exposure to antidopaminergic agents are usually not seen. Here, we report three cases with recurrent OGCs despite complete withdrawal of neuroleptics. Triggering or priming factors were a single dose of haloperidol in two cases and a single dose of metoclopramide in one case. Episodes reoccurred spontaneously, but responded to anticholinergics. The pathomechanisms of acute dystonic reactions and OGCs remain unclear. Parallels to levodopa‐induced dyskinesias in Parkinson's disease, as well as to dopa‐responsive dystonia, paroxysmal dyskinesias, and channelopathies are discussed here. Whether there is a genetic susceptibility or some other reason for only some patients developing this phenomenon remains unclear. © 2009 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>oculogyric crisis</term></item><item><term>acute dystonic reaction</term></item><item><term>dystonia</term></item><item><term>neuroleptics</term></item><item><term>antidopaminergic treatment</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Brief Report</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2008-11-24">Received</change><change when="2009-02-13">Registration</change><change when="2009-06-15">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/F8EDE61931B7C100D8C289490EDA4EEB8B244F4B/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="80"><doi origin="wiley" registered="yes">10.1002/mds.v24:8</doi><numberingGroup><numbering type="journalVolume" number="24">24</numbering><numbering type="journalIssue">8</numbering></numberingGroup><coverDate startDate="2009-06-15">15 June 2009</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="18" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.22532</doi><idGroup><id type="unit" value="MDS22532"></id></idGroup><countGroup><count type="pageTotal" number="5"></count></countGroup><titleGroup><title type="articleCategory">Brief Report</title><title type="tocHeading1">Brief Reports</title></titleGroup><copyright ownership="thirdParty">Copyright © 2009 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2008-11-24"></event><event type="manuscriptAccepted" date="2009-02-13"></event><event type="firstOnline" date="2009-05-01"></event><event type="publishedOnlineFinalForm" date="2009-06-18"></event><event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2009-05-01"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4.7 mode:FullText source:FullText result:FullText" date="2011-02-24"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">1226</numbering><numbering type="pageLast">1229</numbering></numberingGroup><correspondenceTo>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS22532.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="19"></count><count type="wordTotal" number="2377"></count></countGroup><titleGroup><title type="main" xml:lang="en">Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs<link href="#fn1"></link></title><title type="short" xml:lang="en">Tardive Episodic Dystonic Crisis</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Susanne A.</givenNames><familyName>Schneider</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Vrajesh</givenNames><familyName>Udani</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Charulata Sawant</givenNames><familyName>Sankhla</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Kailash P.</givenNames><familyName>Bhatia</familyName><degrees>MD, FRCP</degrees></personName><contactDetails><email>kbhatia@ion.ucl.ac.uk</email></contactDetails></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="GB" type="organization"><unparsedAffiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="IN" type="organization"><unparsedAffiliation>Department of Pediatrics and Neurology, PD Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai, India</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">oculogyric crisis</keyword><keyword xml:id="kwd2">acute dystonic reaction</keyword><keyword xml:id="kwd3">dystonia</keyword><keyword xml:id="kwd4">neuroleptics</keyword><keyword xml:id="kwd5">antidopaminergic treatment</keyword></keywordGroup><fundingInfo><fundingAgency>Brain Research Trust, UK</fundingAgency></fundingInfo><supportingInformation><p> Additional Supporting Information may be found in the online version of this article. </p><supportingInfoItem><mediaResource alt="supporting information" href="urn-x:wiley:08853185:media:mds22532:08-1010early"></mediaResource><caption>Video</caption></supportingInfoItem></supportingInformation><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Adverse events of dopamine‐blocking agents include acute dystonic reactions and oculogyric crises (OGCs). OGCs may be recurrent on maintenance of or re‐exposure to the drug. Thus, complete withdrawal is recommended. Recurrent episodes of acute dystonia despite withdrawal and the lack of further exposure to antidopaminergic agents are usually not seen. Here, we report three cases with recurrent OGCs despite complete withdrawal of neuroleptics. Triggering or priming factors were a single dose of haloperidol in two cases and a single dose of metoclopramide in one case. Episodes reoccurred spontaneously, but responded to anticholinergics. The pathomechanisms of acute dystonic reactions and OGCs remain unclear. Parallels to levodopa‐induced dyskinesias in Parkinson's disease, as well as to dopa‐responsive dystonia, paroxysmal dyskinesias, and channelopathies are discussed here. Whether there is a genetic susceptibility or some other reason for only some patients developing this phenomenon remains unclear. © 2009 Movement Disorder Society</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p>Potential conflict of interest: None reported.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Tardive Episodic Dystonic Crisis</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs</title></titleInfo><name type="personal"><namePart type="given">Susanne A.</namePart><namePart type="family">Schneider</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Vrajesh</namePart><namePart type="family">Udani</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Pediatrics and Neurology, PD Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai, India</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Charulata Sawant</namePart><namePart type="family">Sankhla</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Pediatrics and Neurology, PD Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai, India</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Kailash P.</namePart><namePart type="family">Bhatia</namePart><namePart type="termsOfAddress">MD, FRCP</namePart><affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom</affiliation><description>Correspondence: Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">article</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2009-06-15</dateIssued><dateCaptured encoding="w3cdtf">2008-11-24</dateCaptured><dateValid encoding="w3cdtf">2009-02-13</dateValid><copyrightDate encoding="w3cdtf">2009</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">19</extent><extent unit="words">2377</extent></physicalDescription><abstract lang="en">Adverse events of dopamine‐blocking agents include acute dystonic reactions and oculogyric crises (OGCs). OGCs may be recurrent on maintenance of or re‐exposure to the drug. Thus, complete withdrawal is recommended. Recurrent episodes of acute dystonia despite withdrawal and the lack of further exposure to antidopaminergic agents are usually not seen. Here, we report three cases with recurrent OGCs despite complete withdrawal of neuroleptics. Triggering or priming factors were a single dose of haloperidol in two cases and a single dose of metoclopramide in one case. Episodes reoccurred spontaneously, but responded to anticholinergics. The pathomechanisms of acute dystonic reactions and OGCs remain unclear. Parallels to levodopa‐induced dyskinesias in Parkinson's disease, as well as to dopa‐responsive dystonia, paroxysmal dyskinesias, and channelopathies are discussed here. Whether there is a genetic susceptibility or some other reason for only some patients developing this phenomenon remains unclear. © 2009 Movement Disorder Society</abstract><note type="content">*Potential conflict of interest: None reported.</note><note type="funding">Brain Research Trust, UK</note><subject lang="en"><genre>Keywords</genre><topic>oculogyric crisis</topic><topic>acute dystonic reaction</topic><topic>dystonia</topic><topic>neuroleptics</topic><topic>antidopaminergic treatment</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><note type="content"> Additional Supporting Information may be found in the online version of this article.Supporting Info Item: Video - </note><subject><genre>article category</genre><topic>Brief Report</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><detail type="issue"><caption>no.</caption><number>8</number></detail><extent unit="pages"><start>1226</start><end>1229</end><total>5</total></extent></part></relatedItem><identifier type="istex">F8EDE61931B7C100D8C289490EDA4EEB8B244F4B</identifier><identifier type="DOI">10.1002/mds.22532</identifier><identifier type="ArticleID">MDS22532</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2009 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E56 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000E56 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:F8EDE61931B7C100D8C289490EDA4EEB8B244F4B
|texte= Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs
}}
| This area was generated with Dilib version V0.6.23. |  |